Profile data is unavailable for this security.
About the company
Koninklijke Philips NV is the Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.
- Revenue in EUR (TTM)17.35bn
- Net income in EUR-1.36bn
- Incorporated2000
- Employees79.10k
- LocationRoyal PhilipsHigh Tech Campus 52EINDHOVEN 5656 AGNetherlandsNLD
- Phone+31 205977777
- Fax+31 205977220
- Websitehttps://www.philips.com/
More ▼
Mergers & acquisitions
| Acquired company | PHIA:AEX since announced | Transaction value |
|---|---|---|
| Vesper Holdings LLC | -52.94% | -- |
| Vesper Medical Inc | -52.94% | -- |
Data delayed at least 15 minutes, as of Nov 29 2022 15:45 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ambu A/S | 597.62m | 12.51m | 2.52bn | 4.41k | 226.15 | 5.01 | 48.89 | 4.22 | 0.3716 | 0.3716 | 17.53 | 16.77 | 0.6861 | 1.92 | 6.15 | 1,007,938.00 | 1.44 | 5.08 | 1.72 | 6.27 | 57.47 | 59.90 | 2.09 | 7.08 | 0.932 | -- | 0.3022 | 34.01 | 10.74 | 13.54 | -62.35 | -20.94 | 28.54 | -- |
| Ypsomed Holding AG | 495.68m | 32.01m | 2.65bn | 2.00k | 78.39 | 5.11 | 24.78 | 5.35 | 2.43 | 2.43 | 37.61 | 37.29 | 0.6379 | 5.41 | 6.20 | 252,988.60 | 4.12 | 4.97 | 6.40 | 7.55 | 26.09 | 27.30 | 6.46 | 7.00 | 0.457 | 10.38 | 0.2493 | 24.18 | 15.16 | 3.60 | 297.61 | -12.96 | 27.27 | -14.33 |
| GN Store Nord A/S | 2.36bn | 90.10m | 3.15bn | 8.17k | 32.69 | 3.03 | 10.62 | 1.34 | 5.22 | 5.22 | 136.80 | 56.29 | 0.7187 | 3.06 | 4.89 | 2,423,492.00 | 2.95 | 9.04 | 4.38 | 12.20 | 51.42 | 58.31 | 4.11 | 11.12 | 0.5192 | 5.59 | 0.6911 | 33.63 | 17.29 | 12.77 | 40.26 | 10.09 | 14.20 | 6.15 |
| ConvaTec Group PLC | 2.01bn | 77.48m | 5.48bn | 10.03k | 70.24 | 3.57 | 19.39 | 2.73 | 0.033 | 0.033 | 0.8548 | 0.6485 | 0.5586 | 3.11 | 6.10 | 173,074.50 | 2.16 | 3.20 | 2.53 | 3.59 | 54.11 | 54.24 | 3.86 | 6.31 | 0.9937 | 2.70 | 0.4759 | 94.56 | 7.60 | 3.84 | 4.53 | -- | 6.74 | -- |
| Getinge AB | 2.55bn | 248.05m | 5.48bn | 11.11k | 23.70 | 2.11 | 13.22 | 2.15 | 9.94 | 9.94 | 102.00 | 111.80 | 0.5829 | 2.48 | 6.71 | 2,589,337.00 | 5.73 | 3.34 | 6.90 | 4.45 | 48.67 | 48.06 | 9.83 | 5.78 | 1.43 | 30.71 | 0.151 | 40.67 | -9.29 | 4.06 | -8.31 | 33.59 | -10.36 | 15.20 |
| Amplifon SpA | 2.07bn | 178.28m | 6.34bn | 12.59k | 35.29 | -- | 15.22 | 3.07 | 0.7941 | 0.7685 | 9.22 | -- | -- | -- | -- | 164,390.30 | -- | 4.61 | -- | 6.12 | 24.75 | 55.81 | 8.63 | 7.24 | -- | 9.02 | -- | 29.10 | 29.59 | 11.45 | 64.67 | 20.12 | 12.65 | 30.01 |
| Demant A/S | 2.51bn | 355.69m | 6.46bn | 18.13k | 18.14 | 6.12 | -- | 2.57 | 11.49 | 10.37 | 81.12 | 34.06 | 0.7328 | 2.05 | 5.31 | 1,106,131.00 | 10.42 | 9.07 | 18.49 | 14.78 | 75.16 | 75.23 | 14.22 | 11.96 | 0.5879 | 45.49 | 0.6212 | 0.00 | 23.75 | 8.33 | 140.50 | 13.07 | 11.99 | -- |
| Smith & Nephew plc | 5.04bn | 479.79m | 11.04bn | 18.00k | 23.19 | 2.12 | 10.59 | 2.19 | 0.4728 | 0.4728 | 4.97 | 5.17 | 0.4956 | 0.8075 | 4.13 | 237,325.00 | 4.72 | 6.69 | 5.90 | 8.08 | 71.03 | 72.54 | 9.51 | 12.34 | 0.8356 | 7.99 | 0.3491 | 52.90 | 14.30 | 2.22 | 16.96 | -7.74 | 0.8033 | 5.28 |
| Carl Zeiss Meditec AG | 1.78bn | 245.28m | 11.71bn | 3.75k | 47.87 | -- | 71.79 | 6.57 | 2.74 | 2.74 | 19.87 | -- | -- | -- | -- | 504,527.00 | -- | 8.57 | -- | 10.56 | 59.11 | 56.59 | 13.86 | 11.34 | -- | 6.84 | -- | 36.15 | 23.31 | 8.64 | 93.06 | 19.16 | 18.81 | 16.47 |
| Koninklijke Philips NV | 17.35bn | -1.36bn | 12.44bn | 79.10k | -- | -- | 56.79 | 0.7169 | -1.54 | -1.53 | 19.63 | -- | -- | -- | -- | 221,885.40 | -- | 3.59 | -- | 5.01 | 39.73 | 45.57 | -7.87 | 5.64 | -- | 15.82 | -- | -- | -0.9068 | -0.3072 | -38.65 | -5.05 | 0.1845 | 1.63 |
| Sonova Holding AG | 3.67bn | 658.29m | 15.38bn | 17.07k | 23.49 | 7.48 | 17.09 | 4.19 | 10.51 | 10.51 | 58.71 | 33.00 | 0.6596 | 2.82 | 7.71 | 215,544.10 | 12.03 | 10.50 | 16.19 | 13.55 | 71.11 | 71.80 | 18.24 | 17.47 | 0.8412 | 30.35 | 0.4561 | 33.65 | 29.29 | 7.02 | 14.20 | 12.58 | 1.65 | 13.85 |
| Straumann Holding AG | 2.26bn | 497.86m | 17.77bn | 9.88k | 35.81 | 9.96 | 29.21 | 7.87 | 3.05 | 3.05 | 13.84 | 10.98 | 0.7377 | 1.98 | 5.03 | 244,616.20 | 16.32 | 12.91 | 19.63 | 15.62 | 76.04 | 75.16 | 22.12 | 18.08 | 2.30 | 42.53 | 0.293 | 33.30 | 41.80 | 17.12 | 333.91 | 11.52 | 20.97 | 9.69 |
| Coloplast A/S | 3.04bn | 632.85m | 23.37bn | 14.57k | 39.69 | 22.47 | 30.83 | 7.70 | 22.11 | 22.11 | 106.10 | 39.06 | 0.889 | 2.51 | 6.31 | 1,549,479.00 | 18.53 | 27.73 | 25.34 | 42.87 | 68.78 | 68.12 | 20.84 | 22.59 | 0.7613 | 25.88 | 0.6929 | 89.18 | 16.23 | 7.77 | -2.47 | 4.39 | 10.63 | 5.92 |
Data as of Nov 29 2022. Currency figures normalised to Royal Philips's reporting currency: Euro EUR
24.13%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Artisan Partners LPas of 05 May 2022 | 45.37m | 5.10% |
| The Vanguard Group, Inc.as of 04 Nov 2022 | 23.46m | 2.64% |
| Norges Bank Investment Managementas of 31 Dec 2021 | 22.03m | 2.48% |
| UBS Asset Management (UK) Ltd.as of 18 May 2022 | 21.30m | 2.40% |
| Wellington Management Co. LLPas of 01 Jul 2022 | 19.93m | 2.24% |
| DWS Investment GmbHas of 03 Nov 2022 | 18.03m | 2.03% |
| BlackRock Investment Management LLCas of 24 Nov 2022 | 17.62m | 1.98% |
| Harris Associates LPas of 30 Sep 2022 | 16.75m | 1.88% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 2022 | 15.49m | 1.74% |
| BlackRock Fund Advisorsas of 03 Nov 2022 | 14.62m | 1.64% |
More ▼
Data from 31 Dec 2021 - 30 Sep 2022Source: FactSet Research Systems Inc.
